Literature DB >> 24818805

Advanced bone age in a girl with Wiedemann-Steiner syndrome and an exonic deletion in KMT2A (MLL).

Bryce A Mendelsohn1, Melissa Pronold, Roger Long, Nizar Smaoui, Anne M Slavotinek.   

Abstract

Recognition of the gene implicated in a Mendelian disorder subsequently leads to an expansion of potential phenotypes associated with mutations in that gene as patients with features beyond the core phenotype are identified by sequencing. Here, we present a young girl with developmental delay, short stature despite a markedly advanced bone age, hypertrichosis without elbow hair, renal anomalies, and dysmorphic facial features, found to have a heterozygous, de novo, intragenic deletion encompassing exons 2-10 of the KMT2A (MLL) gene detected by whole exome sequencing. Heterozygous mutations in this gene were recently demonstrated to cause Wiedemann-Steiner syndrome (OMIM 605130). Importantly, retrospective analysis of this patient's chromosomal microarray revealed decreased copy number of two probes corresponding to exons 2 and 9 of the KMT2A gene, though this result was not reported by the testing laboratory in keeping with standard protocols for reportable size cutoffs for array comparative genomic hybridization. This patient expands the clinical phenotype associated with mutations in KMT2A to include variable patterns of hypertrichosis and a significantly advanced bone age with premature eruption of the secondary dentition despite her growth retardation. This patient also represents the first report of Wiedemann-Steiner syndrome due to an exonic deletion, supporting haploinsufficiency as a causative mechanism. Our patient also illustrates the need for sensitive guidelines for the reporting of chromosomal microarray findings that are below traditional reporting size cutoffs, but that impact exons or other genomic regions of known function.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  KMT2A; MLL; Wiedemann-Steiner; array comparative genomic hybridization; bone age; congenital hip dysplasia; developmental delay; hypertrichosis; short stature; vesicoureteral reflux

Mesh:

Substances:

Year:  2014        PMID: 24818805     DOI: 10.1002/ajmg.a.36590

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

1.  Whole exome sequencing reveals a MLL de novo mutation associated with mild developmental delay and without 'hairy elbows': expanding the phenotype of Wiedemann-Steiner syndrome.

Authors:  Dora Steel; Vincenzo Salpietro; Rahul Phadke; Matthew Pitt; Giulia Gentile; Ahmed Massoud; Leigh Batten; Anu Bashamboo; Ken Mcelreavey; Anand Saggar; Maria Kinali
Journal:  J Genet       Date:  2015-12       Impact factor: 1.166

Review 2.  Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease.

Authors:  Jonathan A R Gordon; Janet L Stein; Jennifer J Westendorf; Andre J van Wijnen
Journal:  Bone       Date:  2015-03-31       Impact factor: 4.398

Review 3.  Intellectual Disability: When the Hypertrichosis Is a Clue.

Authors:  Lidia Pezzani; Donatella Milani; Gianluca Tadini
Journal:  J Pediatr Genet       Date:  2015-09-28

4.  Molecular and cellular issues of KMT2A variants involved in Wiedemann-Steiner syndrome.

Authors:  Nicolas Lebrun; Irina Giurgea; Alice Goldenberg; Anne Dieux; Alexandra Afenjar; Jamal Ghoumid; Bertrand Diebold; Léo Mietton; Audrey Briand-Suleau; Pierre Billuart; Thierry Bienvenu
Journal:  Eur J Hum Genet       Date:  2017-12-04       Impact factor: 4.246

5.  Patients with a Kabuki syndrome phenotype demonstrate DNA methylation abnormalities.

Authors:  Nara Sobreira; Martha Brucato; Li Zhang; Christine Ladd-Acosta; Chrissie Ongaco; Jane Romm; Kimberly F Doheny; Regina C Mingroni-Netto; Debora Bertola; Chong A Kim; Ana Ba Perez; Maria I Melaragno; David Valle; Vera A Meloni; Hans T Bjornsson
Journal:  Eur J Hum Genet       Date:  2017-11-07       Impact factor: 4.246

Review 6.  Nervous system development and disease: A focus on trithorax related proteins and chromatin remodelers.

Authors:  Amanda Moccia; Donna M Martin
Journal:  Mol Cell Neurosci       Date:  2017-11-28       Impact factor: 4.314

7.  Mechanism for DPY30 and ASH2L intrinsically disordered regions to modulate the MLL/SET1 activity on chromatin.

Authors:  Young-Tae Lee; Alex Ayoub; Sang-Ho Park; Liang Sha; Jing Xu; Fengbiao Mao; Wei Zheng; Yang Zhang; Uhn-Soo Cho; Yali Dou
Journal:  Nat Commun       Date:  2021-05-19       Impact factor: 14.919

8.  Early-onset primary antibody deficiency resembling common variable immunodeficiency challenges the diagnosis of Wiedeman-Steiner and Roifman syndromes.

Authors:  Delfien J Bogaert; Melissa Dullaers; Hye Sun Kuehn; Bart P Leroy; Julie E Niemela; Hans De Wilde; Sarah De Schryver; Marieke De Bruyne; Frauke Coppieters; Bart N Lambrecht; Frans De Baets; Sergio D Rosenzweig; Elfride De Baere; Filomeen Haerynck
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

9.  A customized high-resolution array-comparative genomic hybridization to explore copy number variations in Parkinson's disease.

Authors:  Valentina La Cognata; Giovanna Morello; Giulia Gentile; Velia D'Agata; Chiara Criscuolo; Francesca Cavalcanti; Sebastiano Cavallaro
Journal:  Neurogenetics       Date:  2016-09-17       Impact factor: 2.660

Review 10.  Modes of Interaction of KMT2 Histone H3 Lysine 4 Methyltransferase/COMPASS Complexes with Chromatin.

Authors:  Agnieszka Bochyńska; Juliane Lüscher-Firzlaff; Bernhard Lüscher
Journal:  Cells       Date:  2018-03-02       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.